Position in BDSX
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$623,848
New position
Shares Held
43,024
first reported quarter
Ownership
0.426%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#14
of 40 holders
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026SEI INVESTMENTS CO holds $1,074,837,549 across 33 Diagnostics & Research names. BDSX ranks #30 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
304,642 | $149,740,681 | |
| 2 | DHR |
Danaher Corp /De/
|
703,077 | $133,303,399 | |
| 3 | CRL |
Charles River Laboratories International, Inc.
|
757,129 | $130,604,752 | |
| 4 | ICLR |
Icon PLC
|
757,489 | $83,823,731 | |
| 5 | QGEN |
Qiagen N.V.
|
1,766,782 | $70,741,950 | |
| 6 | RVTY |
Revvity, Inc.
|
703,406 | $61,625,399 | |
| 7 | LH |
Labcorp Holdings Inc.
|
223,715 | $59,689,397 | |
| 8 | WAT |
Waters Corp /De/
|
197,565 | $58,834,856 |
All Filings in BDSX
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $623,848 | 43,024 | Shares | Sole | 2026-05-13 | |
| No filing history on record for this holder in this stock. | ||||||